Rocket Lab (RKLB) has demonstrated impressive revenue growth and improving margins, but its valuation exceeding 100 times sales raises concerns about future returns. The company's success largely depends on the unproven Neutron rocket, which is critical for future earnings. Given the high expectations and competition from the upcoming SpaceX IPO, the risk/reward balance is uncertain. The analyst recommends a 'Hold' rating, suggesting selling put options to generate yield and possibly enter at a better price later.
On December 1, 2025, YieldMax Ultra Option Income Strategy ETF (ULTY) executed a 1-for-10 reverse split, raising its share price tenfold but not increasing investor value. The fund charges a high 1.24% expense ratio, significantly more than comparabl...
YieldMax Ultra Option Income Strategy ETF (ULTY) promises a high annualized yield near 62% through weekly distributions by selling options on volatile tech stocks. However, its total return over the past year was -4.8%, far below the S&P 500's 22% ga...
